Close
Help





JOURNAL

Breast Cancer: Basic and Clinical Research

Phytohemagglutinin-Induced Mitotic Index in Blood Lymphocytes: A Potential Biomarker for Breast Cancer Risk

Submit a Paper


Breast Cancer: Basic and Clinical Research 2010:4 73-83

Original Research

Published on 15 Dec 2010

DOI: 10.4137/BCBCR.S6307


Further metadata provided in PDF



Sign up for Email Alerts and keep in touch with Breast Cancer: Basic and Clinical Research journal news, updates, events and articles

Abstract

Background: Cell proliferation is associated with the pathogenesis of cancer because it provides opportunities for accumulating genetic mutations. However, biomarkers of cell proliferation in response to environmental stimuli have not been adequately explored for breast cancer risk.

Methods: In a case-control study of 200 breast cancer patients and 360 healthy controls, we investigated the association between phytohemagglutinin (PHA)-induced mitotic index in blood lymphocyte and breast cancer risk.

Results: Having high mitotic index (>3.19%) was associated with an increased risk of breast cancer, with adjusted odds ratios (95% confidence interval) of 1.54 (1.03–2.30) and 2.03 (1.18–3.57) for all women and post-menopausal women, respectively. Mitotic index was correlated with some reproductive factors and body mass index in controls.

Conclusions: Our data suggest increased PHA-induced mitotic index in blood lymphocytes is associated with an increased breast cancer risk and that this association may be modulated by reproductive and other hormones.



Downloads

PDF  (545.60 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML




What Your Colleagues Say About Breast Cancer: Basic and Clinical Research
We are delighted about the speedy and professional process.
Dr Jan Endrikat (Saarland University Hospital, Germany)
More Testimonials

Quick Links


New article and journal news notification services